Cybin (HELP) EPS (Basic) (2020 - 2022)

Cybin (HELP) reported EPS (Basic) of $289281.4 for Q2 2022, up 368397330.73% quarter-over-quarter from -$0.08 in Q1 2021.

Cybin (HELP) EPS (Basic) (2020 - 2022) Analysis & Trends

Cybin has reported EPS (Basic) for 3 years, with the latest figure at $289281.4 in Q2 2022.

For the quarter ending Q2 2022, EPS (Basic) changed N/A year-over-year to $289281.4; the trailing twelve-month figure through Feb 2023 stood at $289281.4 (changed N/A YoY), and the FY2025 full-year result was -$4.02, up 42.42% from the prior year.
EPS (Basic) for Q2 2022 stood at $289281.4, up from -$0.08 in the prior quarter.
The five-year high for EPS (Basic) was $289281.4 in Q2 2022, with the low at -$0.08 in Q1 2021.
Historically, EPS (Basic) has averaged $72320.3 across 3 years, with a median of -$0.05 in 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-0.68
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	3.06
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	0.00
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	0.00
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	0.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	0.00
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	4.06
9	Abivax	91.96 Bn	91.96 Bn	-	-0.06
10	Cybin	75.42 Mn	75.42 Mn	-	-

Download Data